Bwh morning report

30
17F with fever, anemia and splenomegaly A case from Bayalpata Hospital (Nyaya Health) Achham, Nepal

description

 

Transcript of Bwh morning report

Page 1: Bwh morning report

17F with fever, anemia and splenomegaly

A case fromBayalpata Hospital (Nyaya Health)

Achham, Nepal

Page 2: Bwh morning report

Initial presentation on Oct. 7, 2010• HPI: 17F with fevers, chills and rigors x 4 weeks. Of note, had a normal vaginal

delivery approximately 3 weeks prior (on Sept. 17th 2010) at the government district hospital, discharged after one day. As her fevers didn’t subside, she was readmitted to the same hospital and was treated for about a week with an unknown injectable and oral medicines before she was referred to Bayalpata Hospital.

• PMH: Spontaneous abortion of a 3 month old fetus 1 year ago • Medications: None. No discharge summary or referral letter was received from

the government district hospital so we do not know what she received there. • Allergies: NKDA• SH: Used to live with her husband in Mangalsen (about a 5 hour walk from the

hospital for the locals) prior to her illness. Now lives with her father (about 40 minute walk from the hospital). Has studied till Grade 7 before she got married. Does not smoke or drink. Her husband is a student studying in Mangalsen. She does not have any other children. No travel history outside of Achham, no travel to the Terai.

Page 3: Bwh morning report

Patan Hospital, KTM

Bayalpata Hospital,Achham

Nepalgunj MedicalCollege

Doti DistrictHospital

Page 4: Bwh morning report

Nyaya Hospital, Bayalpata

Government District Hospital, Mangalsen

Page 5: Bwh morning report

Physical Exam

• Vitals: T 99, HR 120, BP 90/50, RR 22• General: Thin, very pale• Skin: No jaundice• HEENT: No icterus, PERRLA, EOMI• Heart: faint, tachycardic, regular rhythm, no audible MRGs• Lungs: CTAB• Abd: Splenomegaly up to the umbilicus. No hepatomegaly.

Non-tender, non-distended. +BS.• Ext: No clubbing, cyanosis, edema, no peripheral stigmata of

endocarditis• No notable LAD

Page 6: Bwh morning report
Page 7: Bwh morning report

Labs

– Hb: 5.4 mg/dl– WBC: 6000 with N67, L30, E03– PS for Malaria Parasites: Negative– Na: 133, K: 4.3, – Bilirubin: 1.4 (T), 0.6 (D)– BUN: 8 – Creatinine:0.6 – Blood Glucose level: 91

Page 8: Bwh morning report
Page 9: Bwh morning report

Management at Bayalpata• IV fluids• Ceftriaxone • Metronidazole • Ranitidine • Ferrous sulfate • 24hrs post-admission, the patient’s temperature increased to 106

degrees. Rigors were noted by clinicians. Tachycardia persisted. Chloroquine and primaquine to cover malaria were added.

• At this time, per recommendation of clinicians, family elected to transfer patient to a higher centerSeti Zonal HospitalNepalgunj Medical College

Page 10: Bwh morning report

Patan Hospital, KTM

Bayalpata Hospital,Achham

Nepalgunj MedicalCollege

Doti DistrictHospital

Page 11: Bwh morning report

Nepalgunj Medical CollegeFurther Diagnostic Tests on Oct. 9, 2010• PT:18sec (normal 13 sec), INR:1.5• Hb: 4.5, WBC:2,300 N63 L32 E04, Platelet Count: 45,000• ESR:130• Malaria smear: Positive• Glucose: 104• Normal Urea, Creatinine, Serum Bilirubin, SGPT,SGOT• Alkaline Phosphatase:1236 • Widal: Negative• General Blood Picture: Pancytopenia, P. Vivax• Abdominal ultrasound: Hepatosplenomegaly and Mild Collection seen in Uterine

Cavity• Normal Urine• Blood Group: AB +ve

Page 12: Bwh morning report

Management at NMC

• Treated for Benign Tertian Malaria with Chloroquine and Primaquine

• Also given IV Ceftriaxone• Transfused with 3Units of blood, Hb 4.57• Discharge paperwork mentioned “Pancytopenia

Cause????”• Case referred to Tribhuwan University Teaching Hospital,

Kathmandu. Family members told she likely had a hematologic malignancy. But her parents could not afford to take her to KTM, so she was brought back to Achham.

• What else would we have done in Boston?

Page 13: Bwh morning report
Page 14: Bwh morning report

Readmission to Bayalpata on Oct. 25

She is still having fever with chills and rigors. • Vitals: T 104.0 F, HR 112, BP 110/80, RR 20, weight 36 Kg • Hb: 6.1 gm/dl , WBC:2500 per cubic mm ( Manually) • Blood glucose: 96 mg/dl , Creatinine: 0.6 mg / dl, BUN: 8 mg/dl , Na+: 133

mmol/L , K+:4.2 mmol/L • Serological test for Malaria Parasite (SD Bioline rapid diagnostic tests):

Negative • Peripheral smear for Malaria Parasite: Negative • Peripheral smear: Pancytopenia with no hemolysis• HIV: Negative

Management: • Quinine + Doxycycline (PO)• Supportive care

Page 15: Bwh morning report

Timeline of Events• Oct. 28, 2010: Driven to Doti District Hospital for blood transfusion,

Armed Police Force help• Nov.5, 2010 : Father requested discharge from the hospital so patient

could be seen by a local Jhankri (traditional healer). Fevers better, patient on oral meds so doctors consented.

• Nov. 8, 2010-Nov. 16th 2010: Patient continues to deteriorate at home as family pursues traditional healing. Multiple visits by Nyaya staff and doctors.

• Nov. 16, 2010: 4th visit by Nyaya staff. Family finally consented for patient to be brought back to the hospital by ambulance. Started on Ceftriaxone and empiric TB treatment (Rifampicin, Isoniazid, Pyrazinamide , Ethambutol)

• Nov. 17, 2010: Sent to Doti Hospital for two units of blood.

Page 16: Bwh morning report
Page 17: Bwh morning report

Patan Hospital, Kathmandu

• Nov. 22, 2010• After many logistical hurdles (cost,

transportation, risk of dying en route, who would go with the patient, etc):– driven to Dhangadi (9 hour drive from Achham)– boarded a 1 hr 15 min flight to Kathmandu– Taken by ambulance to Patan Hospital

Page 18: Bwh morning report

Patan Hospital course

• rk39 antigen test POSITIVE• Diagnosis: Kala-Azar (visceral leishmaniasis)• ???

Page 19: Bwh morning report

Leishmaniasis

• Vector-borne disease transmitted by sandflies • Obligate intracellular protozoa of the genus Leishmania• Human infection caused by about 21 of 30 species. E.g.

L. donovani, L. infantum, and L. chagasi, L. mexicana, L. braziliensis, L. peruviana

• Results in 2 main forms of disease, cutaneous leishmaniasis and visceral leishmaniasis (kala-azar)

• Leishmanial species, geographic location, and immune response of the host determine form of disease

Page 20: Bwh morning report

Visceral leishmaniasis

Page 21: Bwh morning report

Geographical distribution

• More than 90 percent of the world's cases of visceral leishmaniasis are in India, Bangladesh, Nepal, Sudan, and Brazil

• Eastern Terai districts of Nepal

Page 22: Bwh morning report

Clinical features

• Fever (can be continuous, intermittent, or remittent and it can recur at irregular intervals)

• Weight loss• Enlarged spleen and liver (usually the spleen is bigger

than the liver)• Some patients have LAD• Patients usually have cytopenias (anemia, leukopenia

and thromobycytopenia)• An important opportunistic infection in areas where it

coexists with HIV

Page 23: Bwh morning report

Diagnosis

• Examination of Giemsa stained slides of the relevant tissue is still the technique most commonly used to detect the parasite.

• rK39 antigen strip test [It should be noted that a positive test result may be the result of previous (subclinical) infection and therefore not relevant to the current illness]

Page 24: Bwh morning report

Treatment

• Pentavalent antimonials, such as sodium stibogluconate (Pentostam) available through the CDC in the US

• Recently, amphotericin B in its liposomal form has been approved and is now considered to be the drug of choice for visceral leishmaniasis

• Liposomal drugs high costprevent the use of liposomal drugs in most countries

• Miltefosine is the sole oral agent that has been shown to be effective

Page 25: Bwh morning report

Our patient’s outcome

• Treatment immediately begun with amphotericin, poor response to infusion (HR 150, RR 50)transferred to ICU

• Liposomal amphotericin b not available in Nepal, costly to import from India, 80-100K Rupees per dose

• Vented, transfused, broad spectrum antibiotics• DIC• Pronounced dead on Nov. 27th morning

Page 26: Bwh morning report

Original Article Single-Dose Liposomal Amphotericin B for Visceral

Leishmaniasis in India

Shyam Sundar, M.D., Jaya Chakravarty, M.D., Dipti Agarwal, M.D., Madhukar Rai, M.D., and Henry W. Murray, M.D.

N Engl J MedVolume 362(6):504-512

February 11, 2010

Page 27: Bwh morning report

Teaching point #1: Differential for massive splenomegaly

• Hematologic (Thalassemia major)• Infectious (Leishmaniasis, hyperreactive malarial

splenomegaly syndrome, MAC)• Infiltrative (lymphoma, myeloproliferative

disorders, Gaucher’s disease)

Page 28: Bwh morning report

Teaching Point #2

• Socio-cultural issues and structural barriers to care in Achham’s setting

– Use of traditional healers– Lack of diagnostic capability – Lack of therapeutics, transfusion capacity– Difficulty of referral– Cost– Transportation

Page 29: Bwh morning report

Teaching Point #3: Visceral leishmaniasis

• Organism: Vector-borne disease transmitted by sandflies, obligate intracellular protozoa of the genus Leishmania

• Clinical features: Fever, Weight loss, HSM, cytopenias

• Dx: Giemsa stain, rK39 antigen strip test• Tx: liposomal amphotericin, antimonials

Page 30: Bwh morning report

Thank you

• Dr. Bikash Gauchan MBBS, Medical Director• Dan Schwarz, Executive Director• Bayalpata Hospital staff• Nyaya team• www.nyayahealth.org